Nano X Imaging Ltd (NNOX)

Currency in USD
4.75
+0.15(+3.26%)
Closed·
Pre Market
4.77+0.02(+0.42%)
·
NNOX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 8 days
Fair Value
Day's Range
4.654.85
52 wk Range
3.7511.00
Key Statistics
Prev. Close
4.75
Open
4.67
Day's Range
4.65-4.85
52 wk Range
3.75-11
Volume
1.33M
Average Volume (3m)
1.06M
1-Year Change
-38.47%
Book Value / Share
2.78
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NNOX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.75
Upside
+84.21%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Nano X Imaging Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Nano X Imaging Ltd Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide and obtain remote interpretations of imaging data; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. The company was founded in 2011 and is headquartered in Petah Tikva, Israel.

Nano X Imaging Ltd SWOT Analysis


AI Imaging Revolution
Nano-X's innovative Nanox.ARC system and AI algorithms aim to transform medical imaging, potentially improving clinical outcomes and healthcare efficiency
Regulatory Milestones
FDA clearance for full-body scans and progress towards CE Mark approval position Nano-X for broader market penetration and international expansion
Market Potential
Analysts estimate a $3.5 billion annual revenue opportunity across healthcare sectors, with expanded FDA indications potentially driving higher system utilization
Financial Outlook
Despite mixed Q1 2024 results, analysts project significant revenue growth. Price targets range from $11 to $17, reflecting varied views on Nano-X's future prospects
Read full SWOT analysis

Nano X Imaging Ltd Earnings Call Summary for Q3/2024

  • Nanox deployed 47 ARC systems in 7 U.S. states; Q3 revenue $3M, with $2.6M from teleradiology and $400K from AI solutions
  • GAAP net loss of $13.6M in Q3; cash position strong at $57.1M in cash and equivalents
  • Anticipates chest and full-body indication approvals, CE Mark, and ArQX launch in 2025
  • AI solutions revenue grew fourfold year-over-year; new FDA 510(k) clearance for AI Health CCNG Version 2.0
  • CEO emphasizes U.S. market importance and upcoming milestones as potential game-changers for the company
Last Updated: 21/11/2024, 15:36
Read Full Transcript

Compare NNOX to Peers and Sector

Metrics to compare
NNOX
Peers
Sector
Relationship
P/E Ratio
−5.6x−1.8x−0.5x
PEG Ratio
−0.36−0.170.00
Price/Book
1.7x1.0x2.6x
Price / LTM Sales
26.3x1.1x3.3x
Upside (Analyst Target)
89.5%54.1%43.5%
Fair Value Upside
Unlock22.0%6.3%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.75
(+84.21% Upside)

Earnings

Latest Release
May 22, 2025
EPS / Forecast
-0.21 / -0.18
Revenue / Forecast
2.82M / 5.83M
EPS Revisions
Last 90 days

NNOX Income Statement

People Also Watch

13.84
OSCR
+1.91%
43.380
SMR
-2.36%
137.93
ALAB
+5.21%
164.82
CRCL
-1.95%

FAQ

What Stock Exchange Does Nano X Trade On?

Nano X is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Nano X?

The stock symbol for Nano X is "NNOX."

What Is the Nano X Market Cap?

As of today, Nano X market cap is 303.14M.

What Is Nano X's Earnings Per Share (TTM)?

The Nano X EPS (TTM) is -0.91.

When Is the Next Nano X Earnings Date?

Nano X will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is NNOX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nano X Stock Split?

Nano X has split 0 times.

How Many Employees Does Nano X Have?

Nano X has 165 employees.

What is the current trading status of Nano X (NNOX)?

As of 05 Aug 2025, Nano X (NNOX) is trading at a price of 4.75, with a previous close of 4.75. The stock has fluctuated within a day range of 4.65 to 4.85, while its 52-week range spans from 3.75 to 11.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.